Agappe Diagnostics Limited - Company Profile

It is a healthcare public limited company based in Mumbai, Maharashtra, India, established in 1998.
1998 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Agappe Diagnostics Limited

Agappe Diagnostics Limited, a active public limited company, was established on 18 June 1998 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24239MH1998PLC115413. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹6.13 Cr.

Formerly known as Agappe Diagnostics Private Limited. It upholds a compliant status. Employing 929 professional, Its leadership includes Mary Baby Meleth (Whole-Time Director), Rhema Elizabeth Thomas (Whole-Time Director), Meena Thomas (Whole-Time Director). Past directors included Mary Baby Meleth, Ananth Narayan Gopalakrishnan, Balagopal Chandrasekhar. It holds ₹251.05 Cr open charges and ₹33.19 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 602 Signature By Lotus, Captain Suresh Sawant Marg,, Off Veera Desai Road, Andheri West, Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1998PLC115413

  • Registration Number

    115413

  • Incorporation Date

    18 June 1998

  • Authorized Capital

    ₹7.00 Cr

  • Paid-Up Capital

    ₹6.13 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 6.13 Cr
  • Company Age 27 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 251.05 Cr
  • Satisfied Charges ₹ 33.19 Cr
  • Revenue Growth **** -11.79%
  • Profit Growth **** -76.05%
  • Ebitda **** -67.49%
  • Net Worth 3.49%
  • Total Assets **** 29.86%
Company report

Agappe Diagnostics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Agappe Diagnostics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Agappe Diagnostics Limited?
Current Directors
Name Designation Appointment Date Status
Mary Baby Meleth Whole-Time Director 01 Jan 2021 Current
Rhema Elizabeth Thomas Whole-Time Director 10 May 2021 Current
Meena Thomas Whole-Time Director 31 May 2007 Current
Joseph John Director 26 Sep 2017 Current
Thomas John Managing Director 01 Jun 2012 Current
Joseph Vadakkekara Antony Director 30 Jun 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 31 Dec 2020 Past
Pramod Abcsdd Director 18 Apr 2022 Past
Pramod Abcsdd Director 21 Jan 2019 Past
Pramod Abcsdd Additional Director 13 Aug 2021 Past
Pramod Abcsdd Whole-Time Director 31 May 2021 Past
Pramod Abcsdd Whole-Time Director 11 Nov 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Agappe Diagnostics.

Agappe Diagnostics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.79% decrease. The company also saw a substantial fall in profitability, with a 76.05% decrease in profit. The company's net worth moved up by a moderate rise of 3.49%.

Agappe Diagnostics revenue growth over time
Agappe Diagnostics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -11.79%
*******
*******
*******
*******
Revenue from Operations
*******
 -11.51%
*******
*******
*******
*******
Total Assets
*******
 29.86%
*******
*******
*******
*******
Profit or Loss
*******
 -76.05%
*******
*******
*******
*******
Net Worth
*******
 3.49%
*******
*******
*******
*******
EBITDA
*******
 -67.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Agappe Diagnostics?

In 2023, Agappe Diagnostics had a promoter holding of 79.77% and a public holding of 20.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,510,500,000.00

Satisfied Charges

₹331,944,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 106.05 Cr
  • Others : 103.00 Cr
  • State Bank Of India : 42.00 Cr
Latest Charge Details
Date Lender Amount Status
03 Jul 2025 State Bank Of India ₹42.00 Cr Open
28 Mar 2024 Others ₹88.00 Cr Open
23 Jan 2023 Others ₹15.00 Cr Open
04 Aug 2012 Axis Bank Limited ₹106.05 Cr Open
16 Aug 2014 The Federal Bank Ltd ₹10.65 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Agappe Diagnostics?

Agappe Diagnostics has a workforce of 929 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Agappe Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agappe Diagnostics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Agappe Diagnostics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Agappe Diagnostics Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.

  • Charges

    A charge with Others of Rs. 88.00 Cr registered on 28 Mar 2024 with Charge ID 100902887 was modified on 16 Sep 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 42.00 Cr with Charge ID 101118059 was registered on 03 Jul 2025. was documented.

  • Balance Sheet

    The activity Agappe Diagnostics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Charges

    A charge with Axis Bank Limited of Rs. 106.05 Cr registered on 04 Aug 2012 with Charge ID 10372923 was modified on 17 Mar 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 88.00 Cr with Charge ID 100902887 was registered on 28 Mar 2024. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Agappe Diagnostics Limited?

The CIN of Agappe Diagnostics Limited is U24239MH1998PLC115413.

Where is Agappe Diagnostics Limited headquartered?

Agappe Diagnostics Limited is headquartered at 602 Signature By Lotus, Captain Suresh Sawant Marg,, Off Veera Desai Road, Andheri West, Mumbai, Maharashtra, 400053.

When was Agappe Diagnostics Limited incorporated?

Agappe Diagnostics Limited was incorporated on 18 June 1998.

Who are the current directors of Agappe Diagnostics Limited?

The current directors of Agappe Diagnostics Limited are

What is the primary industry of Agappe Diagnostics Limited?

The primary industry of Agappe Diagnostics Limited is Manufacturing.

Is Agappe Diagnostics Limited a listed company?

Agappe Diagnostics Limited is unlisted.

What is the capital structure of Agappe Diagnostics Limited?

The authorized capital of Agappe Diagnostics Limited is ₹7.00 Cr, and the paid-up capital is ₹6.13 Cr.

What is the compliance status of Agappe Diagnostics Limited?

The compliance status of Agappe Diagnostics Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available